Prognostic value of podoplanin expression in intratumoral stroma and neoplastic cells of uterine cervical carcinomas

Clinics

Volumn 65, Issue 12, 2010, Pages 1279-1283

  Carvalho, Filomena M ^a   Zaganelli, Fabricia L ^a   Almeida, Bernardo G L ^a   Goes, Joao Carlos Sampaio ^b   Baracat, Edmund C ^a   Carvalho, Jesus P ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b Instituto Brasileiro de Controle do Cancer   (Brazil)

Author keywords

D2 40 antibody; Immunohistochemistry; Intratumoral stromal fibroblasts; Tissue microarray; Uterine cancer

Indexed keywords

MEMBRANE PROTEIN; PDPN PROTEIN, HUMAN; TUMOR MARKER;

ADENOSQUAMOUS CARCINOMA; ANALYSIS OF VARIANCE; ARTICLE; FEMALE; FIBROBLAST; HUMAN; LYMPH NODE METASTASIS; METABOLISM; METASTASIS; MIDDLE AGED; PATHOLOGY; PROGNOSIS; RETROSPECTIVE STUDY; UTERINE CERVIX TUMOR;

ANALYSIS OF VARIANCE; CARCINOMA, ADENOSQUAMOUS; FEMALE; FIBROBLASTS; HUMANS; LYMPHATIC METASTASIS; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; TUMOR MARKERS, BIOLOGICAL; UTERINE CERVICAL NEOPLASMS;

EID: 79951847877     PISSN: 18075932     EISSN: None     Source Type: Journal    
DOI: 10.1590/S1807-59322010001200009     Document Type: Article

References (17)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55:74-108, doi: 10.3322/canjclin.55.2.74.
2. Barnholtz-Sloan J, Patel N, Rollison D, Kortepeter K, MacKinnon J, Giuliano A. Incidence trends of invasive cervical cancer in the United States by combined race and ethnicity. Cancer Causes Control. 2009;20:1129-38, doi: 10.1007/s10552-009-9317-z.
3. Estimate 2010: Incidence of cancer in Brazil. [eletronic] Rio de Janeiro: Brazilian National Cancer Institute; 2009 [cited 2010 04/01/2010]; Available from: http://www.inca.gov.br/estimativa/2010/conteudo_view.asp?ID = 5.
4. Stacker SA, Achen MG, Jussila L, Baldwin ME, Alitalo K. Lymphangiogenesis and cancer metastasis. Nat Rev Cancer. 2002;2:573-83, doi: 10.1038/nrc863.
5. Trimble EL. Cervical cancer state-of-the-clinical-science meeting on pretreatment evaluation and prognostic factors, September 27-28, 2007: proceedings and recommendations. Gynecol Oncol. 2009;114:145-50, doi: 10.1016/j.ygyno.2009.04.003.
6. Guarino M, Rubino B, Ballabio G. The role of epithelial-mesenchymal transition in cancer pathology. Pathology. 2007;39:305-18, doi: 10.1080/ 00313020701329914.
7. Lee JM, Dedhar S, Kalluri R, Thompson EW. The epithelial-mesenchymal transition: new insights in signaling, development, and disease. J Cell Biol. 2006;172:973-81, doi: 10.1083/jcb.200601018.
8. Wicki A, Lehembre F, Wick N, Hantusch B, Kerjaschki D, Christofori G. Tumor invasion in the absence of epithelial-mesenchymal transition: podoplanin-mediated remodeling of the actin cytoskeleton. Cancer Cell. 2006;9:261-72, doi: 10.1016/j.ccr.2006.03.010.
9. Wicki A, Christofori G. The potential role of podoplanin in tumour invasion. Br J Cancer 2007;96:1-5, doi: 10.1038/sj.bjc.6603518.
10. Dumoff KL, Chu C, Xu X, Pasha T, Zhang PJ, Acs G. Low D2-40 immunoreactivity correlates with lymphatic invasion and nodal metastasis in early-stage squamous cell carcinoma of the uterine cervix. Mod Pathol. 2005;18:97-104, doi: 10.1038/modpathol.3800269.
11. Chuang WY, Yeh CJ, Wu YC, Chao YK, Liu YH, Tseng CK, et al. Tumor cell expression of podoplanin correlates with nodal metastasis in esophageal squamous cell carcinoma. Histol Histopathol. 2009;24:1021-7.
12. Yuan P, Temam S, El-Naggar A, Zhou X, Liu DD, Lee JJ, et al. Overexpression of podoplanin in oral cancer and its association with poor clinical outcome. Cancer. 2006;107:563-9, doi: 10.1002/cncr.22061.
13. Yamanashi T, Nakanishi Y, Fujii G, Akishima-Fukasawa Y, Moriya Y, Kanai Y, et al. Podoplanin expression identified in stromal fibroblasts as a favorable prognostic marker in patients with colorectal carcinoma. Oncology. 2009;77:53-62, doi: 10.1159/000226112.
14. Kawase A, Ishii G, Nagai K, Ito T, Nagano T, Murata Y, et al. Podoplanin expression by cancer associated fibroblasts predicts poor prognosis of lung adenocarcinoma. Int J Cancer. 2008;123:1053-9, doi: 10.1002/ijc. 23611.
15. Tavassoli FA DA. Pathology & Genetics Tumours of Breast and Female Genital Organs Lion: International Agency for Research on Cancer - IARC Press;2003.
16. Epi Info. 3.5.1 ed. Atlanta, GA: Centers for Disease Control and Prevention (CDC);2008.
17. Mareel M, Leroy A. Clinical, cellular, and molecular aspects of cancer invasion. Physiol Rev. 2003;83:337-76, doi: 10.1152/physrev.00024.2002.